JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J. Biol. Chem., Vol. 275, Issue 21, 15621-15628, May 26, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Derocq, J.-M.
Right arrow Articles by Casellas, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derocq, J.-M.
Right arrow Articles by Casellas, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60
POSSIBLE INVOLVEMENT OF THE CB2 RECEPTOR IN CELL DIFFERENTIATION*

Jean-Marie DerocqDagger , Omar JbiloDagger , Monsif Bouaboula, Michel Ségui, Christophe Clère, and Pierre Casellas§

From Sanofi-Synthélabo, 34184 Montpellier Cedex 04, France

The function of the peripheral cannabinoid receptor (CB2), which is mainly expressed on hematopoietic cells, remains an enigma. In an attempt to decipher its role, we used AffymetrixTM DNA chips to investigate the gene expression profile of the promyelocytic cells HL-60 transfected with the CB2 receptor and activated with the cannabinoid agonist CP 55,940. Agonist exposure of these cells led to an activation of a mitogen-activated protein kinase cascade and a receptor desensitization, indicating a functional coupling of the transfected receptors. At the genomic level, activation of the CB2 receptors induced an up-regulation of nine genes involved in cytokine synthesis, regulation of transcription, and cell differentiation. A majority of them are under the control of the transcription factor NF-kappa B, whose nuclear translocation was demonstrated. Many features of the transcriptional events, reported here for the first time, appeared to be related to an activation of a cell differentiation program, suggesting that CB2 receptors could play a role in the initialization of cell maturation. Moreover, we showed that CB2-activated wild-type HL-60 cells developed properties usually found in host defense effector cells such as an enhanced release of chemotactic cytokines and an increased motility, characteristic of more mature cells of the granulocytic-monocytic lineage.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger These authors contributed equally to this work.

§ To whom correspondence should be addressed: Sanofi-Synthélabo, 371 rue du Prof. Joseph Blayac, 34184 Montpellier Cedex 04, France. Tel.: 33-467-10-62-90; Fax: 33-467-10-60-00; E-mail: pierre.casellas@ sanofi-synthelabo.com.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. McHugh, C. Tanner, R. Mechoulam, R. G. Pertwee, and R. A. Ross
Inhibition of Human Neutrophil Chemotaxis by Endogenous Cannabinoids and Phytocannabinoids: Evidence for a Site Distinct from CB1 and CB2
Mol. Pharmacol., February 1, 2008; 73(2): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.
Physiol Rev, October 1, 2006; 86(4): 1309 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Gonsiorek, D. Hesk, S.-C. Chen, D. Kinsley, J. S. Fine, J. V. Jackson, L. A. Bober, G. Deno, H. Bian, J. Fossetta, et al.
Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336
J. Biol. Chem., September 22, 2006; 281(38): 28143 - 28151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Kurihara, Y. Tohyama, S. Matsusaka, H. Naruse, E. Kinoshita, T. Tsujioka, Y. Katsumata, and H. Yamamura
Effects of Peripheral Cannabinoid Receptor Ligands on Motility and Polarization in Neutrophil-like HL60 Cells and Human Neutrophils
J. Biol. Chem., May 5, 2006; 281(18): 12908 - 12918.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Benito, W.-K. Kim, I. Chavarria, C. J. Hillard, K. Mackie, R. M. Tolon, K. Williams, and J. Romero
A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis
J. Neurosci., March 9, 2005; 25(10): 2530 - 2536.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. Rockwell and N. E. Kaminski
A Cyclooxygenase Metabolite of Anandamide Causes Inhibition of Interleukin-2 Secretion in Murine Splenocytes
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman
The cannabinoid system and immune modulation
J. Leukoc. Biol., October 1, 2003; 74(4): 486 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Franklin, S. Parmentier-Batteur, L. Walter, D. A. Greenberg, and N. Stella
Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility
J. Neurosci., August 27, 2003; 23(21): 7767 - 7775.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-T. Samson, A. Small-Howard, L. M. N. Shimoda, M. Koblan-Huberson, A. J. Stokes, and H. Turner
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
J. Immunol., May 15, 2003; 170(10): 4953 - 4962.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
H. Friedman, C. Newton, and T. W. Klein
Microbial Infections, Immunomodulation, and Drugs of Abuse
Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
J. Neurosci., February 15, 2003; 23(4): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Parmentier-Batteur, K. Jin, L. Xie, X. O. Mao, and D. A. Greenberg
DNA Microarray Analysis of Cannabinoid Signaling in Mouse Brain in Vivo
Mol. Pharmacol., October 1, 2002; 62(4): 828 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Johnston, W. Jiang, T. Chu, and B. Levine
Identification of Genes Involved in the Host Response to Neurovirulent Alphavirus Infection
J. Virol., November 1, 2001; 75(21): 10431 - 10445.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.